Sunitinib Malate 82293-0017-10
- Manufacturer
- Novugen Pharma (usa) Llc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA218012
Need to source Sunitinib Malate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sunitinib Malate | 50 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
82293-0017-10Selected28 CAPSULE in 1 BOTTLE (82293-017-10)